Regulation of CBD oil
In 2016, the Medicines and Healthcare products Regulatory Agency (MHRA) announced that products containing CBD marketed for medical purposes required regulatory approval for any medical claims. However, CBD oil that is not marketed for medical use has never been a regulated substance in the UK and it is currently legal to possess, buy, and sell CBD oil, providing the product does not contain more than 0.2% tetrahydrocannabinol (THC) and does not claim to have any medicinal benefit.
However, CBD regulation has recently become a point of interest as the UK Food Standards Agency (FSA) have noted that there is a lack of safety and content information on CBD products currently marketed in the UK. Trials carried out on CBD products have also found that some products on sale contain unlisted ingredients or, in some cases, illegal levels of THC, the psychotropic chemical.
As a result of this, on the 13th of February 2020, the FSA gave the CBD industry a deadline of 31st of March 2021 to submit valid novel food authorisation applications for CBD products. After this date, only products which have submitted a valid application will be allowed to remain on the market.